Research Article
The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction
Table 1
The comparison of characteristics and sST2 level between controls and subjects with STEMI.
| Characteristics | Controls, | Subjects with STEMI, | value |
| Demography | Age (years), mean ± SD | 61.0 ± 2.9 | 58.2 ± 8.5 | 0.30 | Male sex, (%) | 8 (80.0) | 76 (80.0) | 0.68 | Body mass index, mean ± SD | 26.3 ± 2.8 | 24.2 ± 2.8 | 0.06 |
| Risk factors | Diabetes mellitus, (%) | 5 (50.0) | 28 (29.5) | 0.18 | Hypertension, (%) | 10 (100.0) | 55 (57.9) | <0.01 | Current smoking, (%) | 2 (20.0) | 50 (52.6) | 0.12 |
| Clinical parameters | Systolic b.p (mmHg), mean ± SD | 132.0 ± 17.5 | 128.9 ± 26.4 | 0.72 | Diastolic b.p (mmHg), mean ± SD | 73.0 ± 9.7 | 78.9 ± 16.4 | 0.41 | Heart rate (bpm), mean ± SD | 73.0 ± 9.7 | 76.1 ± 18.5 | 0.60 |
| Laboratory examination | Hemoglobin (g/dL), mean ± SD | 13.4 ± 1.8 | 13.8 ± 1.8 | 0.48 | Leucocytes (103/mm3), mean ± SD | 8.3 ± 2.8 | 12.8 ± 3.2 | <0.01 | Platelets (103/mm3), mean ± SD | 283.5 ± 48.9 | 276.6 ± 97.7 | 0.83 | Creatinine (mg/dL), mean ± SD | 1.3 ± 0.4 | 1.3 ± 0.5 | 0.58 | Glucose (mg/dL), mean ± SD | 131.2 ± 41.1 | 181.5 ± 94.8 | <0.01 | sST2 (ng/mL), median (q1–q3) | 28.5 (22.7–36.9) | 152.1 (72.0–250.0) | <0.01 |
|
|
b.p = blood pressure; bpm = beat per minute; q1 = first quartile; q3 = third quartile; Mann–Whitney U test. |